The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organisation, is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location. The line can handle batches of up to 1 million units a day and is particularly well suited for the aseptic filling of high-volume products, like vaccines. The company is also expanding its services for the early clinical phases of new drugs. At its Vetter Development Service locations in Chicago, in the US state of Illinois, and Ravensburg, Germany, the company offers a wide range of services, including formulation support and customised packaging development. With another new filling line at the Ravensburg facility and further investments planned in Chicago, Vetter continues to increase its capabilities in clinical manufacturing.
Vetter is reinforcing its position as a strategic partner for the development and commercial manufacturing of parenteral drugs. With the expansion in capacity and service portfolio, Vetter is providing efficient answers to the growing demand for prefilled syringes throughout a product lifecycle. Vetter Development Service supports customers in efficiently transferring new drugs from early stage phase to commercial manufacturing, including regulatory support. The company’s comprehensive know-how in process and packaging development in aseptic filling is used to support a high-professional clinical offering.
"Vetter is continuously and strategically investing in its partnerships with international customers," says Peter Soelkner, Vetter managing director. "In the area of prefilled syringes we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production."
Vetter will be at the BIO 2012 in the Boston Convention and Exhibition Center, in booth number 1825.